Zakład Doświadczalny Roślin Specjalnychsp. z o.o.
Manufacture of pharmaceutical preparations
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2024-02-02
Share capital
5 000,00 PLN
Registered address
ul. Krańcowa 8, 24-100 Puławy, Poland
Financials
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Industry
Bank accounts
Registered as a VAT taxpayer on 2024-04-01. Active
29 1240 2412 1111 0011 3904 4208
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Wiesław Aleksander Oleszek — Vice President of the Management Board
Maciej Piotr Mularski — President of the Management Board
Manner of representation
Joint action by two members of the management board is required to make declarations of will on behalf of the company.
Supervisory board
Joanna Zofia Wiącek — Supervisory Board Member
Katarzyna Mularska — Supervisory Board Member
Wiktoria Mularska — Supervisory Board Member
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 60 | $810.37 | 60% | |
| 40 | $540.25 | 40% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Mariusz Paweł Matyka (48) | Ustawowy reprezentant osoby prawnej posiadającej 100% udziałów w spółce | |
Maciej Piotr Mularski (55) | Natural person holding a senior management position in a parent entity (e.g. parent company). | |
Marcin Mularski (46) | Natural person holding a senior management position in a parent entity (e.g. parent company). | |
Mateusz Mularski (44) | Natural person holding a senior management position in a parent entity (e.g. parent company). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $37,103,878.54 | biomed.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| BIO Animalisp. z o.o. | $48,959.05 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-04-05 | PKD change (Removed: 01.63, 20.14, 21.10, 46.46, 70.22, 72.11, 72.19, 74.9, 77.4; Added: 01.63.Z, 20.14.Z, 21.10.Z, 46.46.Z, 70.22.Z, 72.11.Z, 72.19.Z, 74.90.Z, 77.40.Z) | |
| 2024-02-02 | Entered in the register |
FAQ
The main business activity of Zakład Doświadczalny Roślin Specjalnych focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on February 2, 2024.
The headquarters is located at: ul. Krańcowa 8, 24-100 Puławy.
The management board includes Maciej Piotr Mularski (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-08-28
